Silva Pharmaceuticals Limited (DSE: SILVAPHL)

Silva Pharmaceuticals Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	51.49	38.69	28.64	36.43	58.66	36.41
Short-Term Investments	82.07	88.8	152.72	225.04	211.67	203.04
Cash & Short-Term Investments	133.55	127.49	181.37	261.47	270.33	239.45
Cash Growth	-26.83%	-29.70%	-30.64%	-3.28%	12.90%	-18.61%
Accounts Receivable	248.48	255.72	257.35	255.05	269.91	260
Other Receivables	0.29	0.41	1.97	2.56	2.3	3.43
Receivables	248.76	256.13	259.32	257.61	272.21	263.43
Inventory	471.49	493.2	493.72	482.29	464.18	444.38
Other Current Assets	67.7	62.69	66.02	61.79	68.21	143.03
Total Current Assets	921.52	939.52	1,000	1,063	1,075	1,090
Property, Plant & Equipment	1,463	1,473	1,501	1,480	1,371	1,365
Other Intangible Assets	1.19	1.22	1.36	1.51	1.68	1.18
Total Assets	2,385	2,414	2,503	2,545	2,447	2,456
Accounts Payable	10.12	7.16	6.99	6.9	6.25	6.54
Accrued Expenses	11.69	11.85	12.43	16.25	15.28	14.74
Short-Term Debt	48.94	47.71	55.84	91.01	29.14	26.68
Current Portion of Leases	1.13	1.18	1.42	2.34	5.67	5.72
Current Income Taxes Payable	6.31	5.45	7.9	19.03	30.63	104.82
Other Current Liabilities	0.18	0.82	1.62	2.59	1.52	1.33
Total Current Liabilities	78.37	74.16	86.19	138.11	88.48	159.84
Long-Term Leases	3.16	3.44	4.6	5.75	7.9	13.28
Long-Term Deferred Tax Liabilities	80.82	80.68	77.86	75.68	80.3	84.98
Total Liabilities	162.35	158.28	168.65	219.54	176.68	258.1
Common Stock	1,365	1,365	1,365	1,365	1,365	1,365
Retained Earnings	858.02	890.95	969.08	960.2	905.47	833.11
Shareholders' Equity	2,223	2,256	2,334	2,325	2,270	2,198
Total Liabilities & Equity	2,385	2,414	2,503	2,545	2,447	2,456
Total Debt	53.24	52.33	61.86	99.09	42.71	45.69
Net Cash (Debt)	80.32	75.17	119.51	162.38	227.62	193.76
Net Cash Growth	-37.00%	-37.10%	-26.40%	-28.67%	17.48%	-34.14%
Net Cash Per Share	0.59	0.55	0.88	1.19	1.67	1.42
Filing Date Shares Outstanding	136.5	136.5	136.5	136.5	136.5	136.5
Total Common Shares Outstanding	136.5	136.5	136.5	136.5	136.5	136.5
Working Capital	843.14	865.35	914.23	925.05	986.45	930.44
Book Value Per Share	16.29	16.53	17.10	17.03	16.63	16.10
Tangible Book Value	2,222	2,255	2,333	2,324	2,269	2,197
Tangible Book Value Per Share	16.28	16.52	17.09	17.02	16.62	16.09
Land	342.77	342.77	342.77	342.77	342.77	340.78
Buildings	424.09	424.09	424.09	424.09	424.09	424.09
Machinery	1,148	1,149	1,090	1,072	998.72	980.87
Construction In Progress	321.62	317.67	343.47	274.25	178.47	121.79

Source: S&P Capital IQ. Standard template. Financial Sources.